OR WAIT null SECS
October 12, 2023
The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China.
October 04, 2023
The prize was awarded jointly to Katalin Karikó and Drew Weissman for their groundbreaking discovery regarding modification of the bases in mRNA.
Pfizer has entered into a collaboration with Ginkgo Bioworks to discover novel RNA molecules across priority research areas.
September 26, 2023
The companies plan on targeting the production of abundant, low-cost messenger RNA from C1-cells.
September 15, 2023
Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.
August 17, 2023
Experts discuss the promise of personalized cancer vaccines through the inherent nimbleness of mRNA platform.
August 01, 2023
mRNA may be a modality whose chief advances are yet to come.
July 12, 2023
EMA looks to focus on mRNA vaccines because their classification depends on the target and/or whether they are obtained chemically or biologically.
The acquisition will continue to strengthen the area of conjugate vaccines and bioconjugate drugs and will expand Biosynth’s capabilities from good manufacturing practice facilities located in Berlin, Germany.
June 14, 2023
The new excipients manufacturing facility is expected to be completed in 2025.